Tag Archive for: Massalia Therapeutic

French biotech firm Massalia Therapeutics SA has been launched, backed by seed funding from Landmark Bioventures, the company founders and their network. The company claims to have an IND-ready, first-in-class drug candidate poised to target both cancer and fibrosis.